These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22011450)

  • 1. Ten problematical issues identified by pathology review for multidisciplinary gynaecological oncology meetings.
    McCluggage WG
    J Clin Pathol; 2012 Apr; 65(4):293-301. PubMed ID: 22011450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microinvasive carcinoma in gynaecological pathology.
    Burghardt E
    Clin Obstet Gynaecol; 1984 Apr; 11(1):239-57. PubMed ID: 6370535
    [No Abstract]   [Full Text] [Related]  

  • 3. Frozen section: Its role in gynaecological oncology.
    Moodley M; Bramdev A
    J Obstet Gynaecol; 2005 Oct; 25(7):629-34. PubMed ID: 16263532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts in gynaecological pathology: recent advances and their clinical relevance.
    Ganesan R; Rollason T
    Eur J Surg Oncol; 2006 Sep; 32(7):698-706. PubMed ID: 16765561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pathology review at gynaecological oncology multidisciplinary team meetings: a 5-year prospective analysis of cases with major diagnostic discordance.
    Stewart CJR; Leung YC; Chaudry Z; Koay MHE; Naran A; Plunkett M; Ruba S; Snowball B; Soma A
    Pathology; 2019 Jun; 51(4):353-361. PubMed ID: 31078303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK.
    McCluggage WG; Hirschowitz L; Ganesan R; Kehoe S; Nordin A
    J Clin Pathol; 2010 Sep; 63(9):768-70. PubMed ID: 20696685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved quality of patient care through routine second review of histopathology specimens prior to multidisciplinary meetings.
    Kuijpers CC; Burger G; Al-Janabi S; Willems SM; van Diest PJ; Jiwa M
    J Clin Pathol; 2016 Oct; 69(10):866-71. PubMed ID: 27030307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
    Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
    Radiother Oncol; 2018 Jun; 127(3):404-416. PubMed ID: 29728273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.
    Kuhn E; Ayhan A
    J Clin Pathol; 2018 Feb; 71(2):98-109. PubMed ID: 29183921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues and inconsistencies in the revised gynecologic staging systems.
    Cole L; Stoler MH
    Semin Diagn Pathol; 2012 Aug; 29(3):167-73. PubMed ID: 23062423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current concepts of the surgical management of gynaecological tumours (author's transl)].
    Janisch H
    Wien Klin Wochenschr; 1981 Mar; 93(6):175-8. PubMed ID: 7281692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of terminology and reporting in gynecologic pathology: at last.
    Stoler MH
    Int J Gynecol Pathol; 2013 Jan; 32(1):1-2. PubMed ID: 23202793
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathologist in breast cancer: contemporary issues in the interdisciplinary approach.
    Ibarra JA
    Surg Oncol Clin N Am; 2000 Apr; 9(2):295-317. PubMed ID: 10757846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Close teamwork between pathologist and surgeon can improve results in colorectal cancer treatment].
    West NP; Quirke P; Hagemann-Madsen RH
    Ugeskr Laeger; 2011 Apr; 173(14):1037-40. PubMed ID: 21463553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant treatment of breast cancer: implications for the pathologist].
    Le Guellec S; Perallon R; Alunni JP; Charitansky H; Leaha C; Gonzalez AM; Chateau MC; Simony-Lafontaine J; Jacot W; Gutowski M; Penault-Llorca F; Dalenc F; Lacroix-Triki M
    Ann Pathol; 2011 Dec; 31(6):442-54. PubMed ID: 22172117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study.
    Kidger J; Murdoch J; Donovan JL; Blazeby JM
    BJOG; 2009 Mar; 116(4):511-7. PubMed ID: 19250362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
    Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
    Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance.
    Lopez-Beltran A; Cheng L
    Pathology; 2003 Dec; 35(6):484-91. PubMed ID: 14660098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology slide review in gynecologic oncology: routine or selective?
    Chan YM; Cheung AN; Cheng DK; Ng TY; Ngan HY; Wong LC
    Gynecol Oncol; 1999 Nov; 75(2):267-71. PubMed ID: 10525384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.